查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1497713

藏紅花酸酯市場規模和佔有率分析：依應用（功能性食品和飲料、藥品）-全球收入估算和需求預測（截至 2030 年）

Crocetin Esters Market Size and Share Analysis by Application (Functional Food and Beverages, Pharmaceuticals) - Global Industry Revenue Estimation and Demand Forecast to 2030
出版日期: | 出版商: Prescient & Strategic Intelligence | 英文 230 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球藏花酸酯市場規模預計將從2023年的411,300美元成長到2030年的634,300美元，預測期內複合年增長率為6.5%。

這是由於人們對以植物為基礎的天然成分作為功能性食品和營養補充劑中合成成分的替代品越來越感興趣。不斷增長的健康和保健趨勢、消費者意識的提高、監管環境以及這些化學物質在營養和醫學中的使用也正在推動行業擴張。繼續研究探索藏花酸酯的健康益處和可行應用也進一步推動產業成長。

人口成長和增加糧食產量的需求也推動了該產業的成長。在高度都市化的國家，耕地有限，因此提高現有農業用地的生產力至關重要。透過減少養分外流，藏花酸酯使植物更容易獲得養分，促進植物發育並提高作物產量。

市場洞察：

2023 年，歐洲的產業佔有率最大，達到 45%。該地區的優勢在於自古以來就接受藏紅花。藏紅花是藏紅花酯的原料，該地區各地長期以來都有種植，主要集中在義大利、希臘和西班牙。

預計亞太地區未來幾年將以 10% 的最快複合年增長率成長。這是由於該地區對功能性食品和飲料的需求不斷增長，以及人們越來越關注與抗氧化劑相關的醫療益處。此外，亞太國家的消費者越來越注重健康，因此不僅對天然成分而且對功能性食品成分的需求也很高。

本報告調查了全球藏紅花酸酯市場，並提供了市場定義和概述、市場影響因素分析、市場規模趨勢和預測、各個細分市場/地區/主要國家的詳細分析、競爭環境和主要公司概況的集合等。

目錄

第1章 調查範圍

第2章 研究方法

第3章 執行摘要

第4章 市場指標

第5章 產業展望

  • 市場動態
    • 趨勢
    • 促進因素
    • 抑制因素/問題
    • 促進因素和抑制因素影響分析
  • COVID-19 的影響
  • 波特五力分析

第6章 世界市場

  • 概述
  • 市場收入趨勢/預測：依應用分類
  • 市場收入趨勢與預測：依地區

第7章 北美市場

第8章 歐洲市場

第9章 亞太市場

第10章 拉丁美洲市場

第11章 中東/非洲市場

第12章 美國市場

第13章 加拿大市場

第14章 德國市場

第15章 法國市場

第16章 英國市場

第17章 義大利市場

第18章 西班牙市場

第19章 日本市場

第20章 中國市場

第21章 印度市場

第22章澳洲市場

第23章 韓國市場

第24章 巴西市場

第25章 墨西哥市場

第26章 沙烏地阿拉伯市場

第27章 南非市場

第28章 阿聯酋市場

第29章 競爭格局

  • 主要企業及產品一覽表
  • 各大公司的競爭對標
  • 主要公司的產品基準
  • 近期策略發展

第30章 公司簡介

  • Chengdu Biopurify Phytochemicals Ltd.
  • Chengdu Gelipu Biotechnology Co. Ltd.
  • Tokyo Chemical Industry Co. Ltd
  • Amadis Chemical Company Limited
  • Hunan Jiahang Pharmaceutical Technology Co. Ltd.
  • Cayman Chemical
  • Biosynth
  • Plamed Green Science Group
  • Shaanxi UndersunBiomedtech Co. Ltd.
  • Chongqing Kang Biotechnology Co. Ltd.
  • Hainan Super Biotech Co. Ltd.
  • Xi'an Sgonek Biological Technology Co. Ltd.
  • Kingherbs Limited
  • Xi'an Lyphar Biotech Co. Ltd.

第31章 附錄

簡介目錄
Product Code: 12904

Key Highlights

The crocetin esters market was valued at USD 411.3 thousand in 2023, and it will increase to USD 634.3 thousand, advancing at a 6.5% compound annual growth rate, by 2030.

This is because of the increasing interest in plant-based and natural items as a replacement for synthetic ingredients in functional foods and dietary supplements.

The rising trends of health & wellness, growing consumer consciousness, the regulatory situation, and the usage of these chemicals in nutrition and medicine are also helping the industry expand.

The continuing studies to explore the health benefits and viable applications of crocetin esters are further assisting the growth of the industry.

These mixtures are being examined for their possible role in decreasing oxidative stress, supporting cognitive well-being, and controlling CVDs.

The rising populace and the requirement to enhance food production are also aiding the growth of this industry.

With limited arable land in well-urbanized nations, it has become vital to enhance the productivity of the present farmlands.

Crocetin esters assist in optimizing the accessibility of nutrients for plants by reducing their draining, thus enhancing plant development, which can result in greater crop yields.

Market Insights

Europe accounted for the largest share of the industry in 2023, with a 45% share.

The dominance of this region in the enduring understanding of saffron as well as its acceptance.

Saffron, from which crocetin esters are produced, has been farmed in various areas of this region for quite a long time, notably in Italy, Greece, and Spain.

APAC will advance at the fastest compound annual growth rate, of 10%, in the years to come.

This will be because of the region's rising need for functional foods & beverages and the growing concentration of the medical benefits linked to antioxidants.

Natural as well as functional food ingredients are in high demand because customers in APAC nations become more conscious of their well-being.

The functional food and beverage category accounted for the largest share of the industry in 2023, with a 60% share.

Crocetin esters are progressively being employed in confectionery, dairy, beverages, and convenience foods, because of their important part in protecting these products' stability.

They, similarly, assist in increasing the taste, aroma, and assortment of food & beverages.

Functional foods fulfill people's everyday nutrition requirements, as a result, customers are increasingly searching for them for their overall wellbeing.

Pharmaceuticals will advance at a rapid compound annual growth rate, of 8%, in the years to come.

Due to the robust anti-inflammatory, neuroprotective, and antioxidant features of crocetin esters, pharmaceutical firms have been progressively using them as APIs or various other ingredients in the formulations of drugs.

A growing count of clinical trials and studies are being performed on these bioactive substances to explore their possible therapeutic applications for cardiovascular illnesses, neurological disorders, and tumors.

In the crocetin esters industry, competition circles around the introduction of saffron-derived extracts and research on applications of these mixtures in cosmetics, functional foods, and pharmaceuticals.

The competition in this industry is rather tough, with the existence of several globally operating and localized participants.

Table of Contents

Chapter 1. Research Scope

  • 1.1. Research Objectives
  • 1.2. Market Definition
  • 1.3. Analysis Period
  • 1.4. Market Size Breakdown by Segments
    • 1.4.1. Market size breakdown, by application
    • 1.4.2. Market size breakdown, by region
    • 1.4.3. Market size breakdown, by country
  • 1.5. Market Data Reporting Unit
    • 1.5.1. Value
  • 1.6. Key Stakeholders

Chapter 2. Research Methodology

  • 2.1. Secondary Research
    • 2.1.1. Paid
    • 2.1.2. Unpaid
    • 2.1.3. P&S Intelligence database
  • 2.2. Primary Research
  • 2.3. Market Size Estimation
  • 2.4. Data Triangulation
  • 2.5. Currency Conversion Rates
  • 2.6. Assumptions for the Study
  • 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

  • 5.1. Market Dynamics
    • 5.1.1. Trends
    • 5.1.2. Drivers
    • 5.1.3. Restraints/challenges
    • 5.1.4. Impact analysis of drivers/restraints
  • 5.2. Impact of COVID-19
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Bargaining power of buyers
    • 5.3.2. Bargaining power of suppliers
    • 5.3.3. Threat of new entrants
    • 5.3.4. Intensity of rivalry
    • 5.3.5. Threat of substitutes

Chapter 6. Global Market

  • 6.1. Overview
  • 6.2. Market Revenue, by Application (2017-2030)
  • 6.3. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

  • 7.1. Overview
  • 7.2. Market Revenue, by Application (2017-2030)
  • 7.3. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

  • 8.1. Overview
  • 8.2. Market Revenue, by Application (2017-2030)
  • 8.3. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

  • 9.1. Overview
  • 9.2. Market Revenue, by Application (2017-2030)
  • 9.3. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

  • 10.1. Overview
  • 10.2. Market Revenue, by Application (2017-2030)
  • 10.3. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

  • 11.1. Overview
  • 11.2. Market Revenue, by Application (2017-2030)
  • 11.3. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

  • 12.1. Overview
  • 12.2. Market Revenue, by Application (2017-2030)
  • 12.3. Market Revenue, by Industry (2017-2030)

Chapter 13. Canada Market

  • 13.1. Overview
  • 13.2. Market Revenue, by Application (2017-2030)
  • 13.3. Market Revenue, by Industry (2017-2030)

Chapter 14. Germany Market

  • 14.1. Overview
  • 14.2. Market Revenue, by Application (2017-2030)
  • 14.3. Market Revenue, by Industry (2017-2030)

Chapter 15. France Market

  • 15.1. Overview
  • 15.2. Market Revenue, by Application (2017-2030)
  • 15.3. Market Revenue, by Industry (2017-2030)

Chapter 16. U.K. Market

  • 16.1. Overview
  • 16.2. Market Revenue, by Application (2017-2030)

Chapter 17. Italy Market

  • 17.1. Overview
  • 17.2. Market Revenue, by Application (2017-2030)

Chapter 18. Spain Market

  • 18.1. Overview
  • 18.2. Market Revenue, by Application (2017-2030)

Chapter 19. Japan Market

  • 19.1. Overview
  • 19.2. Market Revenue, by Application (2017-2030)

Chapter 20. China Market

  • 20.1. Overview
  • 20.2. Market Revenue, by Application (2017-2030)

Chapter 21. India Market

  • 21.1. Overview
  • 21.2. Market Revenue, by Application (2017-2030)

Chapter 22. Australia Market

  • 22.1. Overview
  • 22.2. Market Revenue, by Application (2017-2030)

Chapter 23. South Korea Market

  • 23.1. Overview
  • 23.2. Market Revenue, by Application (2017-2030)

Chapter 24. Brazil Market

  • 24.1. Overview
  • 24.2. Market Revenue, by Application (2017-2030)

Chapter 25. Mexico Market

  • 25.1. Overview
  • 25.2. Market Revenue, by Application (2017-2030)

Chapter 26. Saudi Arabia Market

  • 26.1. Overview
  • 26.2. Market Revenue, by Application (2017-2030)

Chapter 27. South Africa Market

  • 27.1. Overview
  • 27.2. Market Revenue, by Application (2017-2030)

Chapter 28. U.A.E. Market

  • 28.1. Overview
  • 28.2. Market Revenue, by Application (2017-2030)

Chapter 29. Competitive Landscape

  • 29.1. List of Market Players and their Offerings
  • 29.2. Competitive Benchmarking of Key Players
  • 29.3. Product Benchmarking of Key Players
  • 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

  • 30.1. Chengdu Biopurify Phytochemicals Ltd.
    • 30.1.1. Business overview
    • 30.1.2. Product and service offerings
    • 30.1.3. Key financial summary
  • 30.2. Chengdu Gelipu Biotechnology Co. Ltd.
    • 30.2.1. Business overview
    • 30.2.2. Product and service offerings
    • 30.2.3. Key financial summary
  • 30.3. Tokyo Chemical Industry Co. Ltd
    • 30.3.1. Business overview
    • 30.3.2. Product and service offerings
    • 30.3.3. Key financial summary
  • 30.4. Amadis Chemical Company Limited
    • 30.4.1. Business overview
    • 30.4.2. Product and service offerings
    • 30.4.3. Key financial summary
  • 30.5. Hunan Jiahang Pharmaceutical Technology Co. Ltd.
    • 30.5.1. Business overview
    • 30.5.2. Product and service offerings
    • 30.5.3. Key financial summary
  • 30.6. Cayman Chemical
    • 30.6.1. Business overview
    • 30.6.2. Product and service offerings
    • 30.6.3. Key financial summary
  • 30.7. Biosynth
    • 30.7.1. Business overview
    • 30.7.2. Product and service offerings
    • 30.7.3. Key financial summary
  • 30.8. Plamed Green Science Group
    • 30.8.1. Business overview
    • 30.8.2. Product and service offerings
    • 30.8.3. Key financial summary
  • 30.9. Shaanxi UndersunBiomedtech Co. Ltd.
    • 30.9.1. Business overview
    • 30.9.2. Product and service offerings
    • 30.9.3. Key financial summary
  • 30.10. Chongqing Kang Biotechnology Co. Ltd.
    • 30.10.1. Business overview
    • 30.10.2. Product and service offerings
    • 30.10.3. Key financial summary
  • 30.11. Hainan Super Biotech Co. Ltd.
    • 30.11.1. Business overview
    • 30.11.2. Product and service offerings
    • 30.11.3. Key financial summary
  • 30.12. Xi'an Sgonek Biological Technology Co. Ltd.
    • 30.12.1. Business overview
    • 30.12.2. Product and service offerings
    • 30.12.3. Key financial summary
  • 30.13. Kingherbs Limited
    • 30.13.1. Business overview
    • 30.13.2. Product and service offerings
    • 30.13.3. Key financial summary
  • 30.14. Xi'an Lyphar Biotech Co. Ltd.
    • 30.14.1. Business overview
    • 30.14.2. Product and service offerings
    • 30.14.3. Key financial summary

Chapter 31. Appendix

  • 31.1. Abbreviations
  • 31.2. Sources and References
  • 31.3. Related Reports